AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Enlivex Ltd. Ordinary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG005ZL1Z95
0.17▼ 0.03 (-12.95%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
0.20
Day's Range
0.17 – 0.18
52-Week Range
0.17 – 7.64
Volume
650.2K
Avg Volume
1.7M
Share Statistics
Shares Outstanding
Employees
34
Exchange
XNAS
Listed
2014-07-31
Share count as of June 30, 2026

Enlivex Ltd. Ordinary Shares (ENLV) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Enlivex Ltd. Ordinary Shares (ENLV)
What is Enlivex Ltd. Ordinary Shares's Market Cap?
Enlivex Ltd. Ordinary Shares's Market Cap is $2.9M, based on as-reported figures from SEC (XBRL) filings.
What is Enlivex Ltd. Ordinary Shares's Trailing P/E?
Enlivex Ltd. Ordinary Shares's Trailing P/E is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Enlivex Ltd. Ordinary Shares's Revenue (TTM)?
Enlivex Ltd. Ordinary Shares's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Enlivex Ltd. Ordinary Shares's Net Income (TTM)?
Enlivex Ltd. Ordinary Shares's Net Income (TTM) is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Enlivex Ltd. Ordinary Shares's EBITDA?
Enlivex Ltd. Ordinary Shares's EBITDA is -$14.7M, based on as-reported figures from SEC (XBRL) filings.
What is Enlivex Ltd. Ordinary Shares's Diluted EPS (TTM)?
Enlivex Ltd. Ordinary Shares's Diluted EPS (TTM) is 73.40, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ENLVAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Operating expenses:
Research and development expenses
General and administrative expenses
Total
Operating loss
Income on digital assets, net
Change in fair value of digital assets purchase option
Finance income (expenses), net
Income (loss) before taxes on income
Taxes on income
Net income (loss)
Basic earnings (loss) per share
Diluted earnings (loss) per share